drugset / Trial / NCT06641037
A Study of LY3866288 in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to evaluate how well LY3866288 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to check how much LY3866288 gets into the bloodstream and how long it takes the body to eliminate it. The study will last up to approximately 9 weeks including screening.
Timeline
- Start
- 2024-10-17
- Primary completion
- 2024-12-02
- Completion
- 2024-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vepugratinib | Unknown | — | Oral |
Indications
No indication recorded.